Yunying Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yunying Wang has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Chuan-Bin Sun
Eye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
1 shared publication - Danni Xu
Eye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China
1 shared publication - Jing-Zhan Zhang
Department of Dermatology and Venereology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
1 shared publication - Jingyi Shi
Department of Dermatology and Venereology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
1 shared publication Peng Wang
Department of Dermatology and Venereology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China
1 shared publication- Shiyang Zhou
Eye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China
1 shared publication
Latest Publications
- Open Access
- 27 April 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Virus-immune signatures reveal distinct clinical phenotypes and predict prognosis in patients with Kaposi’s sarcoma
Kaposi’s sarcoma (KS) is a Kaposi sarcoma-associated herpesvirus (KSHV)-driven multicentric malignancy characterized by substantial clinical heteroge
- 27 April 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Open AccessVirus-immune signatures reveal distinct clinical phenotypes and predict prognosis in patients with Kaposi’s sarcoma
Kaposi’s sarcoma (KS) is a Kaposi sarcoma-associated herpesvirus (KSHV)-driven multicentric malignancy characterized by substantial clinical heteroge
- Open Access
- 22 July 2019
- Published by Springer Nature in BMC Ophthalmology
- Vol. 19 (1) , 1-4
Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report
We report a case of macular hole (MH) formation and retinal detachment after intravitreal conbercept injection for the treatment of choroidal neovascularization (CNV) secondary to degenerative myopia. A 60-year-old woman presented with blurred vision in her left eye was diagnosed as CNV secondary to degenerative myopia. Intravitreal injection of conbercept, an anti -vascular endothelial growth factor (VEGF) agent, was uneventfully performed in the left eye. Unfortunately, a full thickness MH and retinal detachment was found three weeks postoperatively by ophthalmoscopy and spectral-domain optical coherence tomography. Vitrectomy, internal limiting membrane peeling and silicone oil tamponade were then performed, and macular retina was reattached soon after surgery. However, MH still kept open during three months’ follow-up. MH is a quite rare complication of intravitreal anti- VEGF agent injection, tangential contraction secondary to CNV shrinkage and regression caused by anti-VEGF agent is proposed to be the major pathogenesis of MH formation.
- 22 July 2019
- Published by Springer Nature in BMC Ophthalmology
- Vol. 19 (1) , 1-4
Open AccessMacular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report
We report a case of macular hole (MH) formation and retinal detachment after intravitreal conbercept injection for the treatment of choroidal neovascularization (CNV) secondary to degenerative myopia. A 60-year-old woman presented with blurred vision in her left eye was diagnosed as CNV secondary to degenerative myopia. Intravitreal injection of conbercept, an anti -vascular endothelial growth factor (VEGF) agent, was uneventfully performed in the left eye. Unfortunately, a full thickness MH and retinal detachment was found three weeks postoperatively by ophthalmoscopy and spectral-domain optical coherence tomography. Vitrectomy, internal limiting membrane peeling and silicone oil tamponade were then performed, and macular retina was reattached soon after surgery. However, MH still kept open during three months’ follow-up. MH is a quite rare complication of intravitreal anti- VEGF agent injection, tangential contraction secondary to CNV shrinkage and regression caused by anti-VEGF agent is proposed to be the major pathogenesis of MH formation.